Bundamedik Tbk vs Minahasa Membangun Hebat Tbk. — how do they compare? Bundamedik Tbk trades at Rp176 (market cap 1.51T, 536.7K 24h volume), while Minahasa Membangun Hebat Tbk. trades at Rp272 (market cap 285.16B, 4.43M 24h volume). The key difference: Bundamedik Tbk is far larger — about 5.3× Minahasa Membangun Hebat Tbk.'s market cap, and Minahasa Membangun Hebat Tbk. is more actively traded (4.43M versus 536.7K). Which is the better fit depends on your goals.
| BMHS | HBAT | |
|---|---|---|
Market Cap | 1.51T | 285.16B |
Volume | 536.7K | 4.43M |
Lot | 5.37K | 44.33K |
Turnover | 93.41M | 1.17B |
Average Price | 174.05 | 264.91 |
Value | 93.41M | 1.17B |
Indicative Equilibrium Price | 176 | 272 |
Indicative Equilibrium Volume | 100 | 22 |
Trailing returns across standard periods
Latest headlines on both assets
PT Bundamedik Tbk (the “Company”) was established on 13 April 1978 based on Notarial Deed No. 21 of Adlan Yulizar, S.H. The Company strated its commercial operations in 1978. The Company’s parent and ultimate parent of the group is PT Bunda Investama Indonesia.
Read more on BMHS →PT Minahasa Membangun Hebat Tbk was established based on Notarial Deed No. 44 datedJanuary 31, 2020 of Dian Fitriana, S.H., M.Kn., a public notary in Bekasi.
Read more on HBAT →